6[1]Tsutamoto T,Wada A,Maeda K,et al.Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure:pmgnotic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular aysfunction.Circulation,1997,96:509-516.
7[2]Chen HH,Bumett JC.Natriuretic peptides in the pathophysiology of congestive heart failure.Curr Cardiol Rep,2000,2:198-205.
8[3]Bittner V,Weiner DH,Yusuf S,et al.Prediction of mortality and morbidity with a 6 minute walk test in patients with left ventricular dysfunction.SOLVD Investigtors.JAMA,1993,270:1702-1707.
9[5]Bay M,Kirk V,Parner J,et al.NT-proBNP:a new diagnostic screening tool to defferentiate between patients with normal and reduced left ventricular systolic function.Heart,2003,89:150-154.
10[6]Hobbs FD,Davis RC,Roalfe AK,et al.Reliability of N-terminal pro-brain nftriuretic peptide assay in diagnosis of heart failure:cohort study in representative and high risk community populations,BMJ,2002,324:1498.
2DAloia A,Vizzardi E, Bugatti S,et al. Effect of short -term infusivedobutamine therapy on thyroid hormone profile and hemodynamic pa-rameters in patients with acute worsening heart failure and low-tri-iodothyronine syndrome [J]. J Investig Med,2012,60(6) :907-910.
3Alehagen U, Dahlstrm U, Rehfeld JF,et al. Association of copeptinand N -terminal proBNP concentrations with risk of cardiovasculardeath in older patients with symptoms of heart failure [J]. JAMA,2011,305(20):2088-2095.
4Jung JW. Respiratory syncytial virus infection in chiklren with congenital heart disease:global data and interim results of Ko- rean RSV CHD survey. Korean J Pediatr,2011 ,54:192- 196.
5Piechota M, Barylski M, Hannam S, et al. Natriuretic peptides in septic patients. Curr Med Chem, 2009,16 - 4020 -4031.
6Lamp6n N, Hermida-Cadahia EF,Riveiro A,et al. Association between butyrylcbolinesterase activity and low grade systemic inflammation. Ann Hepatol, 2012,11 : 356-363.
7Wang ZY, Aim P, Hakanson R. The contribution of nitric ox- ide to endotoxin-induced ocular inflammation:interaction with sensory nerve fibres. Br J Pharmacol, 2 012,118 : 1537-1543.
